Page last updated: 2024-08-25

ropivacaine and Cardiac Hypertrophy

ropivacaine has been researched along with Cardiac Hypertrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, YS; Kim, OS; Kweon, TD; Na, S; Oh, YJ; Ryoo, S; Shim, HS	1

Other Studies

1 other study(ies) available for ropivacaine and Cardiac Hypertrophy

Article	Year
Cervical ganglion block attenuates the progression of pulmonary hypertension via nitric oxide and arginase pathways. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2 Topics: Amides; Anesthetics, Local; Animals; Arginase; Autonomic Nerve Block; Blood Pressure; Cardiomegaly; Ganglia, Sympathetic; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Ropivacaine; Superior Cervical Ganglion	2014

Article

Year

Cervical ganglion block attenuates the progression of pulmonary hypertension via nitric oxide and arginase pathways.

Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2

Topics: Amides; Anesthetics, Local; Animals; Arginase; Autonomic Nerve Block; Blood Pressure; Cardiomegaly; Ganglia, Sympathetic; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Ropivacaine; Superior Cervical Ganglion

2014